The Effect of Time-Restricted Eating in Cardiometabolic Health
NCT ID: NCT04484987
Last Updated: 2024-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
55 participants
INTERVENTIONAL
2020-11-20
2024-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Time-Restricted Eating in Cardiometabolic Health
NCT05866406
The Effect of Time-restricted Eating on Liver Metabolism
NCT04997486
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults
NCT03459703
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
NCT04647149
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
NCT07189234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRE group
Time-restricted eating group
9 hours daily eating window
Participants assigned to the TRE group will have to consume all their daily meals and snacks during a 9-hour window for 12 weeks.
Control group
Time-unrestricted eating group
15 hours daily eating window
Participants assigned to the control group will have to consume all their daily meals and snacks during a 15-hour window for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
9 hours daily eating window
Participants assigned to the TRE group will have to consume all their daily meals and snacks during a 9-hour window for 12 weeks.
15 hours daily eating window
Participants assigned to the control group will have to consume all their daily meals and snacks during a 15-hour window for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fasting plasma glucose 100-125 mg/dl, or 2h OGTT plasma glucose 140-199 mg/dl or hemoglobin A1C 5.7-6.4%
* self-reported habitual eating period \> 15 h per day
Exclusion Criteria
* fasting \>12 h/day more than once a week or vegan
* shift worker, recent or expected travel crossing time zones
* fasting \>12 h/day more than once a week or vegan
* \> once a week no food intake after 1800 h
* habitually waking up before 0400 h and sleeping before 2230 h
* ≥ 150 min per week of structured exercise
* unstable weight (\>5% change the last 2 months)
* type 2 diabetes or other major chronic disease
* sleep disorder
* cancer in last 5 years
* conditions that render subject unable to complete all testing procedures
* use of medications that affect the study outcome measures or increase the risk of study procedures and that cannot be temporarily discontinued (e.g., steroids, alpha or beta adrenergic blockers or agonists, etc.)
* smoking and illegal drug use
* pregnant or lactating
* menopause
* individuals that have performed procedures involving substantial exposure to radiation in the last 12 months
* gastrointestinal or bariatric surgery
* unable to grant voluntary informed consent or comply with the study instructions
* individuals who are not yet adults (infants, children, teenagers)
* prisoners
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Learn more or sign up for the study here!
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1521859
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.